ctrl K

Barinthus Biotherapeutics (BRNS)

NASDAQ: BRNS · Real-Time Price · USD

0.93

-0.16 (-14.68%)

At close: May 02, 2025, 3:59 PM

0.95

2.27%

After-hours: May 02, 2025, 04:05 PM EDT

Barinthus Biotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	110.66M	142.09M	194.38M	214.05M	43.27M	11.43M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	-8.93M	-4M	n/a	n/a
Other Long-Term Assets	881K	882K	976K	804K	n/a	n/a
Receivables	13M	7.94M	12.21M	7.1M	3.23M	3.91M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.08M	1.47M	563K	995K	n/a	n/a
Total Current Assets	125.74M	156.91M	213.04M	226.76M	47.9M	16.25M
Property-Plant & Equipment	11.76M	19.4M	15.71M	9.09M	2.77M	2.79M
Goodwill & Intangibles	21.95M	37.32M	40.48M	44.06M	n/a	n/a
Total Long-Term Assets	34.59M	57.6M	57.16M	53.95M	2.77M	2.79M
Total Assets	160.33M	214.51M	270.2M	280.71M	50.67M	19.04M
Account Payables	2.47M	1.6M	3.75M	2.42M	4.67M	3.89M
Deferred Revenue	1.74M	n/a	0.00	182K	245K	269.91K
Short-Term Debt	1.92M	n/a	n/a	159K	n/a	n/a
Other Current Liabilities	7.11M	6.01M	1.93M	5.38M	753K	373.89K
Total Current Liabilities	15.66M	12.6M	12.24M	11.16M	7.64M	5.75M
Long-Term Debt	n/a	n/a	n/a	n/a	44.7M	n/a
Other Long-Term Liabilities	14.1M	3.15M	2.68M	2.37M	33.77M	33.76M
Total Long-Term Liabilities	14.54M	14.91M	14.76M	17M	79.94M	35.37M
Total Liabilities	30.19M	27.51M	27M	28.15M	87.58M	41.12M
Total Debt	12.01M	12.98M	8.77M	7.22M	46.36M	1.78M
Common Stock	1K	1K	1K	1K	359.00	330.00
Retained Earnings	-237.66M	-176.59M	-103.24M	-108.58M	-57.72M	-37.89M
Comprehensive Income	-25.87M	-23.32M	-33.46M	-8.49M	-1.24M	-467.36K
Shareholders Equity	130.03M	186.78M	242.9M	252.13M	-37.3M	-22.45M
Total Investments	n/a	-11.18M	-8.93M	-4M	n/a	n/a